Scientific publications

European Journal of Cancer, 2023

FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response prediction

van Eijck C., Strijk G., Vietsch E. et al.

Scientific Reports, 2023

Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study

Mynster Kronborg T., Webel H., O’Connell M. et al.

Journal of Applied Physiology, 2023

Type 2 diabetes exacerbates changes in blood pressure-independent arterial stiffness: cross-sectional and longitudinal evidence from the SUMMIT study

Aizawa K., Gates P., Mawson D. et al.

Translational Neurodegeneration, 2023

A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer’s disease

Faridar A., Eid A., Thome A. et al.

European Journal of Heart Failure, 2023

Growth differentiation factor‐15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR program

Ferreira J., Packer M., Butler J. et al.

Frontiers in Endocrinology, 2023

Proteome profiling identifies circulating biomarkers associated with hepatic steatosis in subjects with Prader-Willi syndrome

Pascut D., Giraudi P., Banfi C. et al.

PLOS ONE, 2023

Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)

Siegbahn A., Eriksson N., Assarsson E. et al.

Journal of Experimental & Clinical Cancer Research, 2023

Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients

Wimmer K., Sachet M., Ramos C. et al.

International Journal of Hygiene and Environmental Health, 2023

Joint association of air pollution exposure and inflammation-related proteins in relation to infant lung function

He S., Lundberg B., Hallberg J. et al.

American Journal of Respiratory and Critical Care Medicine, 2023

Host Response Changes and Their Association with Mortality in COVID-19 Patients with Lymphopenia

Michels E., Appelman B., de Brabander J. et al.

Clinical and Translational Medicine, 2023

Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis

Meng H., Sengupta A., Ricciotti E. et al.

European Heart Journal, 2023

Autoantibodies against the chemokine receptor 3 predict cardiovascular risk

Müller F., Aherrahrou Z., Grasshoff H. et al.

ESC Heart Failure, 2023

Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial

Santos‐Ferreira D., Diaz S., Ferreira J. et al.

BMC Cancer, 2023

Trajectories of immune-related serum proteins and quality of life in patients with pancreatic and other periampullary cancer: the CHAMP study

Hau S., Svensson M., Petersson A. et al.

iScience, 2023

TRAIL-dependent apoptosis of peritoneal mesothelial cells by NK cells promotes ovarian cancer invasion

Steitz A., Schröder C., Knuth I. et al.

Journal of Cardiac Failure, 2023

Pathophysiological Sex Differences in Heart Failure Progression After Acute Coronary Syndrome: Insights From the EXAMINE Trial

Razaghizad A., Aziz H., Zhang G. et al.

Journal of the American College of Cardiology, 2023

Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease

Mazidi M., Wright N., Yao P. et al.

Journal of the American College of Cardiology, 2023

Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure

Ouwerkerk W., Belo Pereira J., Maasland T. et al.

Nature Genetics, 2023

Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis

Stacey S., Zink F., Halldorsson G. et al.

Translational Vision Science & Technology, 2023

Correlation of Aqueous, Vitreous, and Serum Protein Levels in Patients With Retinal Diseases

Wilson S., Siebourg-Polster J., Titz B. et al.